miR-21 in the Extracellular Vesicles (EVs) of Cerebrospinal Fluid (CSF): A Platform for Glioblastoma Biomarker Development

Glioblastoma cells secrete extra-cellular vesicles (EVs) containing microRNAs (miRNAs). Analysis of these EV miRNAs in the bio-fluids of afflicted patients represents a potential platform for biomarker development. However, the analytic algorithm for quantitative assessment of EV miRNA remains under-developed. Here, we demonstrate that the reference transcripts commonly used for quantitative PCR (including GAPDH, 18S rRNA, and hsa-miR-103) were unreliable for assessing EV miRNA. In this context, we quantitated EV miRNA in absolute terms and normalized this value to the input EV number. Using this method, we examined the abundance of miR-21, a highly over-expressed miRNA in glioblastomas, in EVs. In a panel of glioblastoma cell lines, the cellular levels of miR-21 correlated with EV miR-21 levels (p<0.05), suggesting that glioblastoma cells actively secrete EVs containing miR-21. Consistent with this hypothesis, the CSF EV miR-21 levels of glioblastoma patients (n=13) were, on average, ten-fold higher than levels in EVs isolated from the CSF of non-oncologic patients (n=13, p<0.001). Notably, none of the glioblastoma CSF harbored EV miR-21 level below 0.25 copies per EV in this cohort. Using this cut-off value, we were able to prospectively distinguish CSF derived from glioblastoma and non-oncologic patients in an independent cohort of twenty-nine patients (Sensitivity=87%; Specificity=93%; AUC=0.91, p<0.01). Our results suggest that CSF EV miRNA analysis of miR-21 may serve as a platform for glioblastoma biomarker development.

[1]  H. Hollema,et al.  Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma , 2009, BMC Cancer.

[2]  P. Kabos,et al.  CXCR4 expression mediates glioma cell invasiveness , 2006, Oncogene.

[3]  H. D. Vanguilder,et al.  Twenty-five years of quantitative PCR for gene expression analysis. , 2008, BioTechniques.

[4]  N. Kiviat,et al.  Expression of Mir-21 and Mir-143 in Cervical Specimens Ranging from Histologically Normal through to Invasive Cervical Cancer , 2011, PloS one.

[5]  James W. Clancy,et al.  Tumor-derived microvesicles: shedding light on novel microenvironment modulators and prospective cancer biomarkers. , 2012, Genes & development.

[6]  X. Chen,et al.  Argonaute 2 Complexes Selectively Protect the Circulating MicroRNAs in Cell-Secreted Microvesicles , 2012, PloS one.

[7]  Lianbo Yu,et al.  Detection of microRNA Expression in Human Peripheral Blood Microvesicles , 2008, PloS one.

[8]  S. Kalkanis,et al.  Neuro-oncologic applications of exosomes, microvesicles, and other nano-sized extracellular particles. , 2013, Neurosurgery.

[9]  Yuri Kotliarov,et al.  Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. , 2006, Cancer cell.

[10]  Vasco Filipe,et al.  Critical Evaluation of Nanoparticle Tracking Analysis (NTA) by NanoSight for the Measurement of Nanoparticles and Protein Aggregates , 2010, Pharmaceutical Research.

[11]  C. Zurla,et al.  Probes for intracellular RNA imaging in live cells. , 2012, Methods in enzymology.

[12]  Ciro Tetta,et al.  Exosome/microvesicle-mediated epigenetic reprogramming of cells. , 2011, American journal of cancer research.

[13]  Daehee Hwang,et al.  Colorectal cancer cell-derived microvesicles are enriched in cell cycle-related mRNAs that promote proliferation of endothelial cells , 2009, BMC Genomics.

[14]  Bob S Carter,et al.  RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls , 2012, BMC Cancer.

[15]  K. Kosik,et al.  MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. , 2005, Cancer research.

[16]  A. Régnault,et al.  TCR Activation of Human T Cells Induces the Production of Exosomes Bearing the TCR/CD3/ζ Complex1 , 2002, The Journal of Immunology.

[17]  Hamid Cheshmi.  Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers , 2011 .

[18]  Douglas D. Taylor,et al.  Exosomal microRNA: a diagnostic marker for lung cancer. , 2008, Clinical lung cancer.

[19]  Ailin Li,et al.  Plasma specific miRNAs as predictive biomarkers for diagnosis and prognosis of glioma , 2012, Journal of Experimental & Clinical Cancer Research.

[20]  Cicek Gercel-Taylor,et al.  MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. , 2008, Gynecologic oncology.

[21]  J. Davies,et al.  Molecular Biology of the Cell , 1983, Bristol Medico-Chirurgical Journal.

[22]  Student,et al.  THE PROBABLE ERROR OF A MEAN , 1908 .

[23]  T. Curtis,et al.  Deep Sequencing Reveals Predominant Expression of miR-21 Amongst the Small Non-Coding RNAs in Retinal Microvascular Endothelial Cells , 2012, Journal of cellular biochemistry.

[24]  Graça Raposo,et al.  Extracellular vesicles: Exosomes, microvesicles, and friends , 2013, The Journal of cell biology.

[25]  A. Emons,et al.  Boekbespreking: Molecular biology of the cell, B. Alberts, D. Bray, J. Lewis, M. Raff, K. Robers, D.J. Watson. Garland Publ., New York. 1989. , 1990 .

[26]  S. Pastorino,et al.  MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activity. , 2012, Neuro-oncology.

[27]  A. Guha,et al.  Immune infiltration of spontaneous mouse astrocytomas is dominated by immunosuppressive cells from early stages of tumor development. , 2010, Cancer research.

[28]  Kaushal Joshi,et al.  Tumor‐Specific Activation of the C‐JUN/MELK Pathway Regulates Glioma Stem Cell Growth in a p53‐Dependent Manner , 2013, Stem cells.

[29]  E. L. Lehmann,et al.  Introduction to Student (1908) The Probable Error of a Mean , 1992 .

[30]  P. J. Higgins,et al.  Control selection for RNA quantitation. , 2000, BioTechniques.

[31]  Erwin G. Van Meir,et al.  Exciting New Advances in Neuro‐Oncology: The Avenue to a Cure for Malignant Glioma , 2010, CA: a cancer journal for clinicians.

[32]  C. Théry.  Exosomes: secreted vesicles and intercellular communications , 2011, F1000 biology reports.

[33]  A. Magrini,et al.  Static magnetic fields affect cell size, shape, orientation, and membrane surface of human glioblastoma cells, as demonstrated by electron, optic, and atomic force microscopy , 2006, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[34]  J. Pontén,et al.  Two established in vitro cell lines from human mesenchymal tumours , 1967, International journal of cancer.

[35]  S. Chaudhuri,et al.  Microglial action in glioma: a boon turns bane. , 2010, Immunology letters.

[36]  G. Fuller,et al.  Insulin-like growth factor binding protein 2 enhances glioblastoma invasion by activating invasion-enhancing genes. , 2003, Cancer research.

[37]  S. Fulda,et al.  Histone deacetylase inhibitors sensitize glioblastoma cells to TRAIL-induced apoptosis by c-myc-mediated downregulation of cFLIP , 2012, Oncogene.

[38]  Sibel Akyol,et al.  Pregnancy-Associated Exosomes and Their Modulation of T Cell Signaling1 , 2006, The Journal of Immunology.

[39]  S. Aaronson,et al.  In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. , 1973, Journal of the National Cancer Institute.

[40]  S. Grossman,et al.  Current management of glioblastoma multiforme. , 2004, Seminars in oncology.

[41]  M. Kesimer,et al.  Nanoparticle analysis of circulating cell-derived vesicles in ovarian cancer patients. , 2012, Analytical biochemistry.

[42]  Yin-Cheng Huang,et al.  Stereotactic brain biopsy: Single center retrospective analysis of complications , 2009, Clinical Neurology and Neurosurgery.

[43]  S. Stigler.  Francis Galton's Account of the Invention of Correlation , 1989 .

[44]  C. Taccioli,et al.  miRNAs Expression Analysis in Paired Fresh/Frozen and Dissected Formalin Fixed and Paraffin Embedded Glioblastoma Using Real-Time PCR , 2012, PloS one.

[45]  Ugo Orfanelli,et al.  Isolation and Characterization of Tumorigenic, Stem-like Neural Precursors from Human Glioblastoma , 2004, Cancer Research.

[46]  M. Zweig,et al.  Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. , 1993, Clinical chemistry.

[47]  K. Vickers,et al.  Intercellular transport of microRNAs. , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[48]  C. Taccioli,et al.  Definition of miRNAs Expression Profile in Glioblastoma Samples: The Relevance of Non-Neoplastic Brain Reference , 2013, PloS one.

[49]  A. Disch,et al.  Reference genes for the relative quantification of microRNAs in renal cell carcinomas and their metastases. , 2011, Analytical biochemistry.

[50]  F. Slack,et al.  Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[51]  C. Melief,et al.  B lymphocytes secrete antigen-presenting vesicles , 1996, The Journal of experimental medicine.

[52]  D. Webb,et al.  Identification and proteomic profiling of exosomes in human cerebrospinal fluid , 2012, Journal of Translational Medicine.

[53]  M. Zöller,et al.  Exosomal tumor microRNA modulates premetastatic organ cells. , 2013, Neoplasia.

[54]  K Dheda,et al.  Real-time RT-PCR normalisation; strategies and considerations , 2005, Genes and Immunity.

[55]  W. Aird,et al.  A multi-gene transcriptional profiling approach to the discovery of cell signature markers , 2010, Cytotechnology.

[56]  H. H. Andersen,et al.  A Systematic Review of MicroRNA in Glioblastoma Multiforme: Micro-modulators in the Mesenchymal Mode of Migration and Invasion , 2012, Molecular Neurobiology.

[57]  S. Gabriel,et al.  Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. , 2010, Cancer cell.

[58]  R. Barber,et al.  GAPDH as a housekeeping gene: analysis of GAPDH mRNA expression in a panel of 72 human tissues. , 2005, Physiological genomics.

[59]  S. Bustin.  Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. , 2000, Journal of molecular endocrinology.

[60]  M. Wright.  Nanoparticle tracking analysis for the multiparameter characterization and counting of nanoparticle suspensions. , 2012, Methods in molecular biology.

[61]  Susanne Gabrielsson,et al.  Exosomes Containing Glycoprotein 350 Released by EBV-Transformed B Cells Selectively Target B Cells through CD21 and Block EBV Infection In Vitro , 2011, The Journal of Immunology.

[62]  E. Ell,et al.  Comparing the risks of frameless stereotactic biopsy in eloquent and noneloquent regions of the brain: a retrospective review of 284 cases , 2009 .

[63]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[64]  S. Kesari,et al.  A small interference RNA screen revealed proteasome inhibition as strategy for glioblastoma therapy. , 2009, Clinical neurosurgery.

[65]  S. Pomeroy,et al.  Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences. , 2011, Nature communications.

[66]  P. Wen,et al.  Response criteria for glioma , 2008, Nature Clinical Practice Oncology.

[67]  P. Kenny,et al.  miR-21 mediates hematopoietic suppression in MDS by activating TGF-b signaling , 2013 .

[68]  Hakho Lee,et al.  Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy , 2012, Nature Medicine.

[69]  Kaushal Joshi,et al.  MELK-Dependent FOXM1 Phosphorylation is Essential for Proliferation of Glioma Stem Cells , 2013, Stem cells.

[70]  J. Akers,et al.  Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies , 2013, Journal of Neuro-Oncology.

[71]  J. Miller,et al.  Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system , 1987, Molecular and cellular biology.

[72]  Barry Merriman,et al.  U87MG Decoded: The Genomic Sequence of a Cytogenetically Aberrant Human Cancer Cell Line , 2010, PLoS genetics.

[73]  S. Rai,et al.  Identifying mRNA, MicroRNA and Protein Profiles of Melanoma Exosomes , 2012, PloS one.

[74]  Aled Clayton,et al.  Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids , 2006, Current protocols in cell biology.

[75]  A. Merlo,et al.  Frequent Co‐Alterations of TP53, p16/CDKN2A, p14ARF, PTEN Tumor Suppressor Genes in Human Glioma Cell Lines. , 1999, Brain pathology.

[76]  T. Grisar,et al.  Housekeeping genes as internal standards: use and limits. , 1999, Journal of biotechnology.

[77]  C. Roberts,et al.  RNA trafficking by acute myelogenous leukemia exosomes. , 2013, Cancer research.

[78]  Graça Raposo,et al.  Exosomal-like vesicles are present in human blood plasma. , 2005, International immunology.

[79]  E. Kroh,et al.  Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma , 2011, Proceedings of the National Academy of Sciences.